KAP study on cervical cancer and human papillomavirus vaccine acceptability among adolescent girls of Eastern UP: a cross sectional study
Keywords:Cervical cancer, HPV vaccination, Human Papillomavirus, KAP
Background: Human papillomavirus (HPV) is the most common sexually transmitted infection and is a causal factor for cervical cancer in virtually 100% cases. Despite the availability of highly effective vaccine against HPV, the burden of this dreaded disease remains high in our country. The aim of this study was to study the knowledge, attitude and practices on cervical cancer and HPV vaccine among adolescent girls of Eastern UP and to study the factors influencing knowledge, attitude and practices towards HPV vaccination among adolescent girls of this region.
Methods: This was a questionnaire based cross-sectional study. Purposive sampling was used. Sample consisted of adolescent girls attending Gynecological OPD of a tertiary care center of Eastern UP, for a period of one year and the sample size was 384.
Results: The results showed that, only 8.07% participants had heard of HPV infection and 2.08% participants had HPV vaccine knowledge. 35.95% participants agreed that their parents would pay for vaccine and 79.17% participants agreed for vaccination, if it would be free of cost. In total, most of the participants in the sample were found to have a positive attitude towards the vaccine.
Conclusions: Although the knowledge and awareness of cervical cancer and its prevention through HPV vaccination, was poor among adolescent girls of Eastern UP region, it was encouraging to find, that most of them had a positive attitude towards HPV vaccination. It was also concluded, that the acceptability would increase, if the Government includes HPV vaccination in the National Immunization Program. If the cost constraint is dealt with, this completely preventable disease could be controlled in our country.
Bruni L, Albero G, Serrano B, Mena M, Gomez D, Munoz J, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information centre). Human Papillomavirus and Related Diseases in India. Summary Report 17 June 2019.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2018.
National Centre for Disease Informatics and Research, National Cancer Registry Programme, ICMR. Time trends in cancer incidence rates, 1982-2010. Bangalore, India: NCDIR-NCRP (ICMR); 2013.
Kumar N A, Ramnath T, Chaturvedi M. The magnitude of cancer in India. Indian J Med Res. 2009;130(3):219-21.
Plummer M. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609-16.
Ferris D, Samakoses R, Block S. L, et al, Long Term Study of a Quadrivalent Human Papillomavirus Vaccine, Paediatr. 2014;134(3):e657-e665.
Human Papillomavirus Vaccines: WHO position. 2017;19:92,241-68.
Schwarz TF. 10 year follow up on immunogenicity and safety of the Human Papilloma Virus 16/18 As04- Adjuvanted vaccine administered to 10-4 years old girls. Abstract at WSPID 2015, Rio de Janeiro,
Nygard M. evaluation of the long term Anti-Human Papillomavirus 6,11, 16 and 18, Immune response Generated by the Quadrivalent HPV vaccine. Clin Vac Immuno. 2015;22(8):943-8.
Cervical cancer back as top killer among women. Sushmi Dey/TNN/Updated: May 4, 2016.
Andrade C, Menon V, Ameen S, Praharaj SK. designing and conducting knowledge, attitude and practice surveys in psychiatry: Practical guidance. Indian J Psychol Med. 2020;42(5):478-81.
Kyriazos TA, Stalikas A. Applied psychometrics: the steps of scale development and standardization process. Psycho. 2018;9(11):2531-60.
Juntasopeepun, P. Davidson, P. M. Suwan, N. Phianmongkhol et al. Human Papillomavirus Vaccination Intention among Young Women in Thailand. Asian Pacific J Can Preven. 2011;12(12):3213-9.
Singh J, Roy B, Yadav A. Cervical cancer awareness and HPV vaccine acceptability among females in Delhi: A cross-sectional study. Ind J Can. 2018;55(3):233-7.
Montgomery MP, Dune T, Shetty PK, Shetty AK. knowledge and Acceptability of Human Papillomavirus Vaccination and Cervical Cancer Screening among Women in Karnataka. Ind J Can Educ. 2015;30(1):130-7.
Charakorn C, Rattanasiri S, Lertkhachonsuk AA Thanapprapasr D, Chittithaworn S, Wilailak S. knowledge of Pap smear, HPV and HPV vaccine and the acceptability of HPV vaccine by Thai women. Asia-Pacific J Clin Onco. 2011;7(2):160-7.
Basu P, Sarkar S, Mukherjee S. Women’s perceptions and social barriers determine compliance to cervical screening: Results from a population-based study in India. Can Detect Prev. 2016;30(4):369-74.
Perlman S, Wamai RG, Bain PA, Welty T, Welty E, et al. Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review. PLoS ONE. 2014;9(3):e90912.
Chatterjee P.Delhi first state to launch HPV vaccine as public health programme in schools. The Indian Express. New Delhi: Indian Express Group. 2016.